Paul Brown, Radiation Oncologist at Mayo Clinic, shared a post on LinkedIn։
“Randomized Trial PCNSL Better Cognitive Outcomes, PFS with WBRT!
OS Benefit only seen in older (>60 yo)? due to less salvage options․”
Title: Multicenter Randomized Phase II Study of R-MPV-A Chemoimmunotherapy With or Without Low-Dose Whole-Brain Radiotherapy for Newly-Diagnosed Primary CNS Lymphoma
Authors: Antonio Omuro, Lisa DeAngelis, Mei-Yin Polley, Denise Correa, Jeffrey Wefel, Joseph Bovi, Marc Rosenblum, Benjamin Corn, Sanjay Aneja, Christian Grommes, David Peereboom, Enrico Lallana, Maria Werner-Wasik, Leland Rogers, Fabio Iwamoto, Hsiang-Hsuan Michael Yu, Eric Donnelly, Timothy Struve, Minhee Won, Minesh Mehta
Read the Full Article in Neuro-Oncology.
More posts featuring Paul Brown.
